BRKR (STOCKS)
Bruker Corporation
$56.630000
+2.400000 (+4.43%)
Prev close: $54.230000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Frank H. Laukien
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $8,620.56M
- Employees
- 11,396
- P/E (TTM)
- -225.58
- P/B (TTM)
- 3.37
- Dividend Yield
- 36.88%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
7
Buy
7
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$0.31 | $0.24 | +0.0718 | +30.14% |
|
Dec 2025 (Q4)
|
$0.59 | $0.66 | -0.0722 | -10.90% |
|
Sep 2025 (Q3)
|
$0.45 | $0.34 | +0.1083 | +31.69% |
|
Jun 2025 (Q2)
|
$0.32 | $0.43 | -0.1125 | -26.01% |
Financial Statements
| Revenues | $3.46B |
| Benefits Costs and Expenses | $3.44B |
| Cost Of Revenue | $1.89B |
| Costs And Expenses | $3.44B |
| Gross Profit | $1.57B |
| Nonoperating Income/Loss | -$27.80M |
| Operating Expenses | $1.52B |
| Selling, General, and Administrative Expenses | $963.20M |
| Research and Development | $399.40M |
| Other Operating Expenses | $157.10M |
| Operating Income/Loss | $46.60M |
| Income/Loss From Continuing Operations After Tax | -$4.30M |
| Income/Loss From Continuing Operations Before Tax | $18.80M |
| Income Tax Expense/Benefit | $23.10M |
| Net Income/Loss | -$9.40M |
| Net Income/Loss Attributable To Noncontrolling Interest | $2.20M |
| Net Income/Loss Attributable To Parent | -$11.60M |
| Net Income/Loss Available To Common Stockholders, Basic | -$36.40M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $24.80M |
| Preferred Stock Dividends And Other Adjustments | $24.80M |
| Basic Earnings Per Share | -$0.24 |
| Diluted Earnings Per Share | -$0.24 |
| Basic Average Shares | 455,700,000 |
| Diluted Average Shares | 456,300,000 |
| Assets | $6.13B |
| Current Assets | $2.10B |
| Inventory | $1.12B |
| Prepaid Expenses | $41.00M |
| Other Current Assets | $941.10M |
| Noncurrent Assets | $4.03B |
| Fixed Assets | $719.60M |
| Other Non-current Assets | $3.31B |
| Liabilities | $3.66B |
| Current Liabilities | $1.36B |
| Accounts Payable | $269.10M |
| Other Current Liabilities | $1.09B |
| Noncurrent Liabilities | $2.31B |
| Long-term Debt | $1.67B |
| Other Non-current Liabilities | $637.30M |
| Redeemable Noncontrolling Interest | $35.80M |
| Equity | $2.47B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $2.47B |
| Temporary Equity | $35.80M |
| Liabilities And Equity | $6.13B |
| Net Cash Flow From Operating Activities | $140.30M |
| Net Cash Flow From Operating Activities, Continuing | $140.30M |
| Net Cash Flow From Investing Activities | -$210.10M |
| Net Cash Flow From Investing Activities, Continuing | -$210.10M |
| Net Cash Flow From Financing Activities | -$18.60M |
| Net Cash Flow From Financing Activities, Continuing | -$18.60M |
| Exchange Gains/Losses | $38.30M |
| Net Cash Flow | -$50.10M |
| Net Cash Flow, Continuing | -$88.40M |
| Comprehensive Income/Loss | -$23.70M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $5.10M |
| Comprehensive Income/Loss Attributable To Parent | -$28.80M |
| Other Comprehensive Income/Loss | -$14.30M |
| Other Comprehensive Income/Loss Attributable To Parent | -$14.30M |